» Articles » PMID: 3458229

Immune Clearance of Liposomes Inhibited by an Anti-Fc Receptor Antibody in Vivo

Overview
Specialty Science
Date 1986 Apr 1
PMID 3458229
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In a study designed to evaluate the potential for in vivo manipulation of the circulation and tissue distribution of injected liposomes, mice were passively injected with antidinitrophenyl (anti-DNP) monoclonal antibodies of the IgG2a or IgG2b subclasses or were immunized with the nitrophenyl hapten bound to a protein carrier. They were then injected i.v. with 125I- and carboxyfluorescein-labeled, DNP-bearing liposomes. Circulation time of the DNP-bearing liposomes was markedly reduced in actively and passively immune mice, with increased deposition of liposomes in the liver. The increased clearance of liposomes could be abrogated by injection of a monoclonal antibody directed against the murine IgG Fc receptor (2.4G2). The results suggest that clearance of ligand-bearing reagent in the face of an immune response may be modified by specific immunologic manipulation in vivo.

Citing Articles

Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer.

Yari H, Nkepang G, Awasthi V Materials (Basel). 2019; 12(5).

PMID: 30841602 PMC: 6427334. DOI: 10.3390/ma12050756.


Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.

Glassman P, Muzykantov V J Pharmacol Exp Ther. 2019; 370(3):570-580.

PMID: 30837281 PMC: 6806371. DOI: 10.1124/jpet.119.257113.


Unintended effects of drug carriers: Big issues of small particles.

Parhiz H, Khoshnejad M, Myerson J, Hood E, Patel P, Brenner J Adv Drug Deliv Rev. 2018; 130:90-112.

PMID: 30149885 PMC: 6588191. DOI: 10.1016/j.addr.2018.06.023.


Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.

Greineder C, Villa C, Walsh L, Kiseleva R, Hood E, Khoshnejad M Bioconjug Chem. 2017; 29(1):56-66.

PMID: 29200285 PMC: 6477694. DOI: 10.1021/acs.bioconjchem.7b00592.


Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.

Greineder C, Hood E, Yao A, Khoshnejad M, Brenner J, Johnston I J Control Release. 2016; 226:229-37.

PMID: 26855052 PMC: 4964279. DOI: 10.1016/j.jconrel.2016.02.006.


References
1.
PARASKEVAS F, Lee S, Orr K, ISRAELS L . A receptor for Fc on mouse B-lymphocytes. J Immunol. 1972; 108(5):1319-27. View

2.
Reininger L, Fueri J, Boned A, Prat M, Landolfo S, Rubin B . On the molecular basis of T-helper-cell function. IV. B-lymphocyte-promotor factors: on their mode of action, biochemical nature and possible relationship to molecules involved in specific T-helper-cell activity. Cell Immunol. 1985; 92(1):85-104. DOI: 10.1016/0008-8749(85)90067-x. View

3.
Fraker P, SPECK Jr J . Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978; 80(4):849-57. DOI: 10.1016/0006-291x(78)91322-0. View

4.
Segal D, Titus J . The subclass specificity for the binding of murine myeloma proteins to macrophage and lymphocyte cell lines and to normal spleen cells. J Immunol. 1978; 120(4):1395-403. View

5.
Unkeless J . Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979; 150(3):580-96. PMC: 2185638. DOI: 10.1084/jem.150.3.580. View